Sunday, August 2, 2015

Keep cool and carry on...

Delayed graft function (DGF) after kidney transplant is associated with long-term allograft dysfunction. Niemann et al. (NEJM 2015;373:405) reported that therapeutic hypothermia reduced DGF (defined here as the requirement of dialysis in the recipient within 7 days after renal transplantation).

Study group enrolled 370 kidney donors after neurological determination of death (DNDDs), randomized to either normothermia (36.5 to 37.5 deg., n= 280) vs. mild hypothermia (34-35 deg. either by allowing to spontaneously reach the temperature, or by passive-cooling devices or forced-air systems, n=286). Incidence of DGF was significantly lower in hypothermia group (28.2% vs 39.2%, p=0.008), and study was terminated early.  

Therapeutic hypothermia (targeted temperature management) is an established intervention for outside-hospital cardiac arrest to protect neurological function.
In transplant field, in contrast, current organ procurement protocol (e.g. one from NATCO) has a stipulation that normal body temperature should be maintained in donors, frequently requiring active warming with warm blankets.
 What is the protective mechanism?  Authors discussed possible contribution of ischemia-reperfusion injury. Is this procedure applicable to other organs? Many questions arise and there is a nice open forum with NEJM group to discuss these (til August 7th EDT).

Naoka Murakami, MD PhD

No comments:

Post a Comment

Renal Fellow Network encourages comments and discussion regarding the posts. Do not post any comments that are commercial or advertising in nature. Posts will be deleted if commercial or advertising comments are made. Internet users commenting on the Renal Fellow Network must post information which is true and correct to their knowledge. Sources to health/medical claims must be provided when relevant. Moderators reserve the right to erase, without notification, any comment they would judge inappropriate.